ASX - By Stock
|
TRI |
Re:
Ann: MEB Begins Implementation of ilumen In the United Kingdom
|
|
john12
|
58 |
15K |
8 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
58
|
15K
|
8
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
2 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
61
|
13K
|
2
|
|
ASX - By Stock
|
BOE |
Re:
Ann: Trading Halt
|
|
john12
|
58 |
18K |
2 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
58
|
18K
|
2
|
|
ASX - By Stock
|
GRV |
Re:
GRV - Share price & chart discussion
|
|
john12
|
1.6K |
417K |
4 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
1.6K
|
417K
|
4
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
1 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
0 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
61
|
13K
|
0
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
1 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
2 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
61
|
13K
|
2
|
|
ASX - By Stock
|
TKM |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
john12
|
61 |
13K |
1 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Half Yearly Report and Accounts
|
|
john12
|
26 |
9.9K |
1 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
26
|
9.9K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Half Yearly Report and Accounts
|
|
john12
|
26 |
9.9K |
4 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
26
|
9.9K
|
4
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
2 |
25/01/21 |
25/01/21 |
ASX - By Stock
|
692
|
197K
|
2
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
8 |
23/01/21 |
23/01/21 |
ASX - By Stock
|
692
|
197K
|
8
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Medibio Granted CE Mark Approval for MEBsleep
|
|
john12
|
92 |
27K |
2 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
92
|
27K
|
2
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
21/01/21 |
21/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Medibio Granted CE Mark Approval for MEBsleep
|
|
john12
|
92 |
27K |
7 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
92
|
27K
|
7
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
20/01/21 |
20/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Medibio Granted CE Mark Approval for MEBsleep
|
|
john12
|
92 |
27K |
1 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
92
|
27K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Medibio Granted CE Mark Approval for MEBsleep
|
|
john12
|
92 |
27K |
3 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
92
|
27K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Medibio Granted CE Mark Approval for MEBsleep
|
|
john12
|
92 |
27K |
2 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
92
|
27K
|
2
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
18/01/21 |
18/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
17/01/21 |
17/01/21 |
ASX - By Stock
|
692
|
197K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
17/01/21 |
17/01/21 |
ASX - By Stock
|
692
|
197K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
1 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
497
|
216K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: Consumer Mental Health App Initial testing phase commenced
|
|
john12
|
3 |
2.0K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
3
|
2.0K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: US FDA advises further data needed for MEBsleep approval
|
|
john12
|
43 |
14K |
2 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
43
|
14K
|
2
|
|
ASX - By Stock
|
BOE |
Re:
Uranium News
|
|
john12
|
497 |
216K |
0 |
08/01/21 |
08/01/21 |
ASX - By Stock
|
497
|
216K
|
0
|
|
ASX - By Stock
|
TRI |
Re:
Ann: US FDA advises further data needed for MEBsleep approval
|
|
john12
|
43 |
14K |
3 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
43
|
14K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Ann: US FDA advises further data needed for MEBsleep approval
|
|
john12
|
43 |
14K |
6 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
43
|
14K
|
6
|
|
ASX - By Stock
|
TRI |
Re:
Ann: US FDA advises further data needed for MEBsleep approval
|
|
john12
|
43 |
14K |
7 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
43
|
14K
|
7
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
6 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
692
|
197K
|
6
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
2 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
692
|
197K
|
2
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
692
|
197K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
692
|
197K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
692
|
197K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
692
|
197K
|
3
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
692
|
197K
|
1
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
11 |
16/12/20 |
16/12/20 |
ASX - By Stock
|
692
|
197K
|
11
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
6 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
692
|
197K
|
6
|
|
ASX - By Stock
|
TRI |
Re:
Ann: FDA Strategy and Regulatory Update
|
|
john12
|
692 |
197K |
1 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
692
|
197K
|
1
|
|